Thiogenesis Therapeutics, Corp. (TSXV:TTI)
Canada · Delayed Price · Currency is CAD 0.8200
+0.0300 (3.80%)
Jul 22, 2025, 4:00 PM EDT
Thiogenesis Therapeutics Market Cap
Thiogenesis Therapeutics has a market cap or net worth of CAD 37.97 million as of July 24, 2025. Its market cap has increased by 6.02% in one year.
Market Cap
37.97M
Enterprise Value
34.96M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.82
Market Cap Chart
Since April 13, 2022, Thiogenesis Therapeutics's market cap has increased from 13.96M to 37.97M, an increase of 172.10%. That is a compound annual growth rate of 35.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 23, 2025 | 37.97M | 37.53% |
| Dec 31, 2024 | 27.61M | -17.40% |
| Dec 29, 2023 | 33.43M | 48.30% |
| Dec 30, 2022 | 22.54M | 61.52% |
| Apr 13, 2022 | 13.96M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Green Thumb Industries | 1.80B |
| Sienna Senior Living | 1.67B |
| dentalcorp Holdings | 1.61B |
| Curaleaf Holdings | 1.28B |
| WELL Health Technologies | 1.19B |
| Trulieve Cannabis | 1.15B |
| Cronos Group | 1.09B |
| Extendicare | 1.06B |